婴幼儿持续性呼吸急促/神经内分泌细胞增生症的诊断评估与临床发现:欧洲多中心回顾性研究
该欧洲多中心回顾性研究纳入17国378例PTI/NEHI患儿,中位诊断年龄9个月,最常见基线症状为呼吸急促、胸壁凹陷、听诊湿啰音、低氧血症和生长迟缓。所有患儿均行HRCT,23.5%行肺活检且随时间下降、随国家而异,52.8%活检显示肺神经内分泌细胞增生;基因检测罕见且国家间差异大。诊断依赖临床症状和HRCT,需指南标准化诊断流程。
要点
- PTI/NEHI诊断主要依靠临床症状和HRCT影像,肺活检较少使用。
- 肺活检使用率23.5%且随时间下降,与诊断延迟延长相关。
- 各国在检查数量和类型上存在差异,亟需标准化诊断指南。
核心结论
- PTI/NEHI诊断依赖临床症状和HRCT影像结果,肺活检较少进行。
- 各国在检查数量和类型上存在差异,需要指南标准化诊断方法。
研究设计与样本
- 欧洲多中心、回顾性、观察性研究,纳入17国378例PTI/NEHI患儿。
- 分析并比较各国临床特征和诊断策略。
主要发现
- 378例患儿中63.5%为男性,97.4%为白人,中位诊断年龄9个月(IQR 6-13个月)。
- 最常见基线症状为呼吸急促、胸壁凹陷、听诊湿啰音、低氧血症和生长迟缓。
- 所有患儿均行HRCT,多数行胸部X线、超声心动图和免疫学检查。
- 23.5%患儿行肺活检,使用率随时间下降且随国家而异,与诊断延迟延长相关。
- 组织病理学显示52.8%患儿有肺神经内分泌细胞增生;基因检测罕见且国家间差异显著。
关键数值与推荐
- 肺活检使用率23.5%,且随时间下降、随国家而异;组织病理学显示52.8%患儿有肺神经内分泌细胞增生。
- 所有患儿均行HRCT;基因检测罕见且应用国家间差异显著。
- 胃食管反流病和OSA评估、婴儿肺功能测试和肺超声等未确立作用检查仅限于单个国家。
临床怎么用
- 临床可依据症状和HRCT诊断PTI/NEHI,避免不必要的肺活检。
- 需注意各国诊断策略差异,推动标准化诊断流程。
局限性
- 回顾性观察性设计可能存在选择偏倚和信息偏倚。
- 未报告统一诊断标准,各国诊断方法差异可能影响结果比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Persistent tachypnea of infancy (PTI) or neuroendocrine cell hyperplasia of infancy (NEHI) is a form of childhood interstitial lung disease (chILD) that predominantly affects young children. Although it is one of the most common chILDs, no unified diagnostic approach specific to this condition exists. RESEARCH QUESTION: Are the clinical presentation and the diagnostic approach different in patients with PTI/NEHI among European countries? STUDY DESIGN AND METHODS: This was a European multicenter, retrospective, observational study. Data on clinical characteristics and diagnostic strategies in patients with PTI/NEHI were analyzed and compared across participating countries. RESULTS: The study included 378 children with PTI/NEHI from 17 countries (63.5% male, 97.4% White) who received a diagnosis at a median age of 9 months (interquartile range, 6-13 months). The most common baseline symptoms were tachypnea, chest retractions, crackles on auscultation, hypoxemia, and failure to thrive. High-resolution CT (HRCT) imaging was performed in all patients, with most undergoing chest radiography, echocardiography, and immunology tests. Lung biopsy was carried out in 23.5% of patients, with a decreasing trend over time and variation by country; its use was associated with longer diagnostic delay. Histopathologic examination showed a hyperplasia of pulmonary neuroendocrine cells in 52.8% of patients. Genetic testing was rare, and its application varied significantly among countries. Additional investigations that do not have an established role, such as assessment for gastroesophageal reflux disease and OSA, infant pulmonary function tests, and lung ultrasound, were limited to single countries. INTERPRETATION: Diagnosis of PTI/NEHI relies on clinical symptoms and HRCT imaging results, with lung biopsies less commonly performed. Differences exist among countries regarding the number and type of investigations. A need exists for guidelines that will standardize the diagnostic approach.
引用
- Marczak H, Krenke K, Griese M, et al. Diagnostic Evaluation and Clinical Findings in Children With Persistent Tachypnea of Infancy/Neuroendocrine Cell Hyperplasia of Infancy: A European Multicenter Retrospective Study. Chest. 2025. PMID: 40054602. doi:10.1016/j.chest.2025.02.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。